KLRS

Kalaris Therapeutics, Inc. SEC filings

Every EDGAR filing for Kalaris Therapeutics, Inc. (KLRS), newest first, with AI summaries and stories.

Ticker
KLRS
CIK
1754068
Latest filing
Aug 28

Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16) · usually files the same day as earnings

Watch in the app Get the app

Get an email when Kalaris Therapeutics, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  1. ROUTINE4Kalaris Therapeutics, Inc.KLRS

    2 insider filings

    Laurie Keating, insider filing for KLRS

    Show all 2
    • 4Insider filing for KLRS
    • 3New insider at KLRS

    Laurie Keating, reporting

  2. ROUTINE4Kalaris Therapeutics, Inc.KLRS

    2 insider filings

    Liisa Ann Bayko, insider filing for KLRS

    Show all 2
    • 4Insider filing for KLRS
    • 3New insider at KLRS

    Liisa Ann Bayko, reporting

  3. ROUTINE4Kalaris Therapeutics, Inc.KLRS

    7 insider filings

    Morana Jovan-Embiricos, insider filing for KLRS

    Show all 7
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS

    Morana Jovan-Embiricos, reporting

  4. ROUTINE424B3Kalaris Therapeutics, Inc.KLRS

    2 structured-note prospectuses

    Securities offering

    Show all 2
    • 424B3Securities offering
    • 424B3Securities offering
  5. ROUTINE4Kalaris Therapeutics, Inc.KLRS

    3 insider filings

    Matthew Gall, insider filing for KLRS

    Show all 3
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS
    • 4Insider filing for KLRS

    Matthew Gall, reporting

Older filings on EDGAR